Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsBreast NeoplasmsCisplatinCombined Modality TherapyDoxorubicinLung NeoplasmsCyclophosphamideTreatment OutcomeNeoplasmsCell Line, TumorDrug Resistance, NeoplasmDisease-Free SurvivalOvarian NeoplasmsSurvival AnalysisNeoplasm StagingGene Expression Regulation, NeoplasticPrognosisSurvival RateNeoplasm MetastasisNeoadjuvant TherapyEtoposidePaclitaxelColonic NeoplasmsApoptosisTumor Cells, CulturedDrug Administration ScheduleMice, NudeStomach NeoplasmsNeoplasm InvasivenessCell ProliferationNeoplasm Recurrence, LocalAntineoplastic Agents, PhytogenicCarcinoma, Non-Small-Cell LungMethotrexateTaxoidsCarboplatinPancreatic NeoplasmsAdenocarcinomaAntimetabolites, AntineoplasticColorectal NeoplasmsVinblastineDeoxycytidineFollow-Up StudiesOrganoplatinum CompoundsXenograft Model Antitumor AssaysInduction ChemotherapyCell SurvivalTumor Markers, BiologicalCarcinomaDrug Screening Assays, AntitumorDose-Response Relationship, DrugNeoplasm ProteinsRNA, Small InterferingAntibiotics, AntineoplasticBleomycinCarcinoma, Squamous CellDisease ProgressionIfosfamideReverse Transcriptase Polymerase Chain ReactionAnthracyclinesTime FactorsEarly Detection of CancerBone NeoplasmsAntineoplastic Agents, AlkylatingProspective StudiesReceptor, erbB-2Liver NeoplasmsRNA, MessengerReceptors, EstrogenBlotting, WesternTesticular NeoplasmsKaplan-Meier EstimateRadiotherapyNeoplasm TransplantationClinical Trials as TopicRadiotherapy, AdjuvantSignal TransductionSalvage TherapyChemotherapy, Cancer, Regional PerfusionUrinary Bladder NeoplasmsCytarabineCamptothecinCell CycleCell DivisionTumor Suppressor Protein p53NeutropeniaAntibodies, Monoclonal, HumanizedTamoxifenAntibodies, MonoclonalProstatic NeoplasmsDrug SynergismDown-RegulationNauseaVomitingCell MovementBrain NeoplasmsTransplantation, HeterologousLymphoma, Non-Hodgkin